These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Benefit-risk assessment of nesiritide in the treatment of acute decompensated heart failure. Yancy CW Drug Saf; 2007; 30(9):765-81. PubMed ID: 17722969 [TBL] [Abstract][Full Text] [Related]
7. Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure. Aronson D; Burger AJ Am Heart J; 2004 Nov; 148(5):e16. PubMed ID: 15523294 [TBL] [Abstract][Full Text] [Related]
8. Nesiritide: harmful or harmless? Dorsch MP; Rodgers JE Pharmacotherapy; 2006 Oct; 26(10):1465-78. PubMed ID: 16999657 [TBL] [Abstract][Full Text] [Related]
9. Rationale and design of the Acute Study of Clinical Effectiveness of Nesiritide in Decompensated Heart Failure Trial (ASCEND-HF). Hernandez AF; O'Connor CM; Starling RC; Reist CJ; Armstrong PW; Dickstein K; Lorenz TJ; Gibler WB; Hasselblad V; Komajda M; Massie B; McMurray JJ; Nieminen M; Rouleau JL; Swedberg K; Califf RM Am Heart J; 2009 Feb; 157(2):271-7. PubMed ID: 19185633 [TBL] [Abstract][Full Text] [Related]
10. Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials. Sackner-Bernstein JD; Kowalski M; Fox M; Aaronson K JAMA; 2005 Apr; 293(15):1900-5. PubMed ID: 15840865 [TBL] [Abstract][Full Text] [Related]
11. Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine. Wang DJ; Dowling TC; Meadows D; Ayala T; Marshall J; Minshall S; Greenberg N; Thattassery E; Fisher ML; Rao K; Gottlieb SS Circulation; 2004 Sep; 110(12):1620-5. PubMed ID: 15337695 [TBL] [Abstract][Full Text] [Related]
15. Effects of nesiritide and predictors of urine output in acute decompensated heart failure: results from ASCEND-HF (acute study of clinical effectiveness of nesiritide and decompensated heart failure). Gottlieb SS; Stebbins A; Voors AA; Hasselblad V; Ezekowitz JA; Califf RM; O'Connor CM; Starling RC; Hernandez AF J Am Coll Cardiol; 2013 Sep; 62(13):1177-83. PubMed ID: 23747790 [TBL] [Abstract][Full Text] [Related]
16. Nesiritide for the treatment of decompensated heart failure. Wylie JV; Tsao L Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):803-13. PubMed ID: 15500426 [TBL] [Abstract][Full Text] [Related]
17. Nesiritide: a novel approach for acute heart failure. Vichiendilokkul A; Tran A; Racine E Ann Pharmacother; 2003 Feb; 37(2):247-58. PubMed ID: 12549957 [TBL] [Abstract][Full Text] [Related]
18. Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group. Colucci WS; Elkayam U; Horton DP; Abraham WT; Bourge RC; Johnson AD; Wagoner LE; Givertz MM; Liang CS; Neibaur M; Haught WH; LeJemtel TH N Engl J Med; 2000 Jul; 343(4):246-53. PubMed ID: 10911006 [TBL] [Abstract][Full Text] [Related]
19. Nesiritide for the treatment of congestive heart failure. Iyengar S; Feldman DS; Trupp R; Abraham WT Expert Opin Pharmacother; 2004 Apr; 5(4):901-7. PubMed ID: 15102572 [TBL] [Abstract][Full Text] [Related]
20. Clinical and hemodynamic effects of nesiritide (B-type natriuretic peptide) in patients with decompensated heart failure receiving beta blockers. Abraham WT; Cheng ML; Smoluk G; Congest Heart Fail; 2005; 11(2):59-64. PubMed ID: 15860969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]